UNAM researchers test silver nanoparticles for veterinary cancer treatment

Scientists from the National Autonomous University of Mexico (UNAM), in collaboration with the autonomous universities of Baja California and Guadalajara, are testing a silver nanoparticle formulation called Argovit to treat cancer in dogs and cats.

The research, conducted by the Center for Nanoscience and Nanotechnology (CNyN), aims to use the properties of silver at a nanometric scale to target tumor cells selectively. Preliminary results suggest the treatment can inhibit tumor proliferation and slow disease progression without the severe toxicity typically associated with traditional chemotherapy.

Currently, eight animals are participating in the experimental protocol. While the treatment is not described as a cure, researchers report improvements in quality of life and mobility in some patients. The team is continuing to study optimal dosages, specific cancer types, and the most effective stages of the disease for intervention.